BON:F Boiron SA

EUR 33.50 -0.30 -0.887574
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

EUR 33.50

-0.30 (-0.89)%

EUR 0.61B

100.00

N/A

N/A

Icon

BON:F

Boiron SA (EUR)
COMMON STOCK | F
EUR 33.50
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

EUR 0.61B

N/A

EUR 33.50

Boiron SA (BON:F) Stock Forecast

N/A

Based on the Boiron SA stock forecast from 0 analysts, the average analyst target price for Boiron SA is not available over the next 12 months. Boiron SA’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Boiron SA is Slightly Bullish , which is based on 8 positive signals and 4 negative signals. At the last closing, Boiron SA’s stock price was EUR 33.50. Boiron SA’s stock price has changed by -2.19% over the past week, +1.06% over the past month and -13.44% over the last year.

No recent analyst target price found for Boiron SA
No recent average analyst rating found for Boiron SA

Company Overview Boiron SA

Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary homeopathic medicines and homeopathic specialties; and other healthcare products include medical devices, invitro diagnostics, ...Read More

https://www.boiron.fr

2, avenue de l?Ouest Lyonnais, Messimy, France, 69510

2,501

December

EUR

Germany

Adjusted Closing Price for Boiron SA (BON:F)

Loading...

Unadjusted Closing Price for Boiron SA (BON:F)

Loading...

Share Trading Volume for Boiron SA Shares

Loading...

Compare Performance of Boiron SA Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for BON:F

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Boiron SA (Sector: Drug Manufacturers - Specialty & Generic )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
MRKC:F
MERCK KGAA NAM.SP.ADR -0.20 (-0.61%) EUR72.69B N/A 13.13

ETFs Containing BON

Symbol Name BON's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Boiron SA (BON:F) Stock

Stock Target Advisor's fundamental analysis for Boiron SA's stock is Slightly Bullish .

BON:F stock's dividend yield is 3.86%. Our analysis grades BON:F stock's dividend yield at C-. This means that BON:F stock's dividend yield is above 71% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the F exchange. Based on this BON:F may be a average dividend stock for its sector.

Unfortunately we do not have enough data on BON:F's stock to indicate what its average analyst target is.

BON:F stock's Price/Earning ratio is 16.97. Our analysis grades BON:F stock's Price / Earning ratio at F. This means that BON:F stock's Price/Earning ratio is above 46% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the F exchange. Based on this BON:F may be fairly valued for its sector

The last closing price of BON:F's stock was EUR 33.50.

The most recent market capitalization for BON:F is EUR 0.61B.

Unfortunately we do not have enough analyst data on BON:F's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Boiron SA's stock.

As per our most recent records Boiron SA has 2,501 Employees.

Boiron SA's registered address is 2, avenue de l?Ouest Lyonnais, Messimy, France, 69510. You can get more information about it from Boiron SA's website at https://www.boiron.fr.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...